Clinical Journal of Pain · 2008 · 32 citations · 33 references
Study results suggest that BTXA treatment has some efficacy when administered within 1 year of the WI. However, a large, well-designed clinical trial is needed to draw final conclusions.
33
Botulinum Toxin Type A as a Migraine Preventive Treatment
Stephen D. Silberstein, Ninan T. Mathew, Joel R. Saper et al. · Headache The Journal of Head and Face Pain · 2000 · 540 citations · Full text